127 related articles for article (PubMed ID: 17987071)
1. [Use and misuse of steroids to newborn].
Størdal K; Lunde J
Tidsskr Nor Laegeforen; 2007 Nov; 127(21):2806-9. PubMed ID: 17987071
[TBL] [Abstract][Full Text] [Related]
2. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial.
Doyle LW; Davis PG; Morley CJ; McPhee A; Carlin JB;
Pediatrics; 2006 Jan; 117(1):75-83. PubMed ID: 16396863
[TBL] [Abstract][Full Text] [Related]
3. Inhaled drugs for the prevention and treatment of bronchopulmonary dysplasia.
Pantalitschka T; Poets CF
Pediatr Pulmonol; 2006 Aug; 41(8):703-8. PubMed ID: 16779858
[TBL] [Abstract][Full Text] [Related]
4. Antenatal glucocorticoid treatment decreases mortality and chronic lung disease in survivors among 23- to 28-week gestational age preterm infants.
Figueras-Aloy J; Serrano MM; Rodríguez JP; Pérez CF; Serradilla VR; Jiménez JQ; González RJ;
Am J Perinatol; 2005 Nov; 22(8):441-8. PubMed ID: 16283604
[TBL] [Abstract][Full Text] [Related]
5. Neonatal hydrocortisone treatment: neurodevelopmental outcome and MRI at school age in preterm-born children.
Rademaker KJ; Uiterwaal CS; Groenendaal F; Venema MM; van Bel F; Beek FJ; van Haastert IC; Grobbee DE; de Vries LS
J Pediatr; 2007 Apr; 150(4):351-7. PubMed ID: 17382109
[TBL] [Abstract][Full Text] [Related]
6. Minidex: very low dose dexamethasone (0.05 mg/kg/day) in chronic lung disease.
Yates HL; Newell SJ
Arch Dis Child Fetal Neonatal Ed; 2011 May; 96(3):F190-4. PubMed ID: 21115554
[TBL] [Abstract][Full Text] [Related]
7. [Diuretics in preterm infants].
Semama DS
Arch Pediatr; 2006 Apr; 13(4):379-87. PubMed ID: 16472998
[TBL] [Abstract][Full Text] [Related]
8. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease.
Hasan J; Beharry KD; Valencia AM; Strauss A; Modanlou HD
Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766
[TBL] [Abstract][Full Text] [Related]
9. Inhaled nitric oxide to prevent bronchopulmonary dysplasia in preterm neonates.
Mercier JC; Olivier P; Loron G; Fontaine R; Maury L; Baud O
Semin Fetal Neonatal Med; 2009 Feb; 14(1):28-34. PubMed ID: 18986855
[TBL] [Abstract][Full Text] [Related]
10. The role of inhaled steroids in the treatment of bronchopulmonary dysplasia.
Avent ML; Gal P; Ransom JL
Neonatal Netw; 1994 Apr; 13(3):63-9. PubMed ID: 7512192
[TBL] [Abstract][Full Text] [Related]
11. Impact of perinatal corticosteroids on neuromotor development and outcome: review of the literature and new meta-analysis.
Shinwell ES; Eventov-Friedman S
Semin Fetal Neonatal Med; 2009 Jun; 14(3):164-70. PubMed ID: 19109083
[TBL] [Abstract][Full Text] [Related]
12. Effects of higher versus lower dexamethasone doses on pulmonary and neurodevelopmental sequelae in preterm infants at risk for chronic lung disease: a meta-analysis.
Onland W; De Jaegere AP; Offringa M; van Kaam AH
Pediatrics; 2008 Jul; 122(1):92-101. PubMed ID: 18595991
[TBL] [Abstract][Full Text] [Related]
13. The effect of postnatal steroids on growth and development.
Halliday HL
J Perinat Med; 2001; 29(4):281-5. PubMed ID: 11565195
[TBL] [Abstract][Full Text] [Related]
14. Postnatal glucocorticoids in preterm neonates: use in French neonatal centres in 2006.
Autret-Leca E; Bauer S; Alberti C; Jonville-Béra AP; Aujard Y; Bensouda-Grimaldi L; Baud O
Arch Dis Child Fetal Neonatal Ed; 2008 Sep; 93(5):F398. PubMed ID: 18723787
[No Abstract] [Full Text] [Related]
15. Postnatal intravenous steroids and long-term neurological outcome: recommendations from meta-analyses.
Yates HL; Newell SJ
Arch Dis Child Fetal Neonatal Ed; 2012 Jul; 97(4):F299-303. PubMed ID: 21427126
[TBL] [Abstract][Full Text] [Related]
16. Two-year follow-up of a randomised trial with repeated antenatal betamethasone.
Peltoniemi OM; Kari MA; Lano A; Yliherva A; Puosi R; Lehtonen L; Tammela O; Hallman M;
Arch Dis Child Fetal Neonatal Ed; 2009 Nov; 94(6):F402-6. PubMed ID: 19531521
[TBL] [Abstract][Full Text] [Related]
17. Intrauterine, early neonatal, and postdischarge growth and neurodevelopmental outcome at 5.4 years in extremely preterm infants after intensive neonatal nutritional support.
Franz AR; Pohlandt F; Bode H; Mihatsch WA; Sander S; Kron M; Steinmacher J
Pediatrics; 2009 Jan; 123(1):e101-9. PubMed ID: 19117831
[TBL] [Abstract][Full Text] [Related]
18. Evidence-based neonatal drug therapy for prevention of bronchopulmonary dysplasia in very-low-birth-weight infants.
Schmidt B; Roberts R; Millar D; Kirpalani H
Neonatology; 2008; 93(4):284-7. PubMed ID: 18525211
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence and risk factors of bronchopulmonary dysplasia among extremely low birth weight newborns of regional birth cohort of south-east Poland].
Kwinta P; Grudzień A; Pawlik D; Olechowski W; Lauterbach R; Pietrzyk JJ
Przegl Lek; 2009; 66(1-2):14-20. PubMed ID: 19485250
[TBL] [Abstract][Full Text] [Related]
20. Decreased use of postnatal corticosteroids in extremely preterm infants without increasing chronic lung disease.
Seth R; Gray PH; Tudehope DI
Neonatology; 2009; 95(2):172-8. PubMed ID: 18776732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
